Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Primary Peritoneal Carcinoma
Related studies linked through entity extraction aliases.
A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Women With Folate Receptor (FR) Alpha Positive Advanced Epithelial Ovarian Cancer (EOC), Primary Peritoneal or Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Total/Subtotal Colectomy in Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malignancies
- Status
- COMPLETED
- Phase
- NA
Study of Tremelimumab Alone or Combined With Olaparib for Patients With Persistent EOC (Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma)
- Status
- TERMINATED
- Phase
- PHASE1
Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Trial of Weekly Paclitaxel With Oncothermia and Weekly cisPlatin With Oncothermia in Patients With Recurrent or Persistent Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Cytoreduction With or Without Intraoperative Intraperitoneal Hyperthermic Chemotherapy (HIPEC) in Patients With Peritoneal Carcinomatosis From Ovarian Cancer, Fallopian Tube or Primary Peritoneal Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
- Status
- COMPLETED
- Phase
- N/A
Dose Escalation of Cisplatin Hyperthermic Intraperitoneal Chemotherapy After Surgery in Patients With Unresectable Stage IIIC Ovarian, Tube or Peritoneal Primary Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1
DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
HOT: HIPEC in Ovarian Cancer as Initial Treatment
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Intraperitoneal Natural Killer Cells and INCB024360 for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Advanced Epithelial Ovarian Carcinomas
- Status
- UNKNOWN
- Phase
- PHASE2
Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior Therapies
- Status
- COMPLETED
- Phase
- PHASE2
Tivozanib As Maintenance Therapy In GYN
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Demcizumab Plus Paclitaxel in Subjects With Platinum Resistant Ovarian
- Status
- TERMINATED
- Phase
- PHASE1